Genmab A/S

About Genmab A/S

Genmab is a biotechnology company focused on transforming the treatment of cancer and other serious diseases through pioneering antibody science. Their mission is to improve the lives of patients by creating and developing innovative antibody-based therapeutics, rooted in science and inspired by patient needs.

Products & Services

Approved Medicines:Eight approved medicines incorporating Genmab innovation for the treatment of cancer and other serious diseases.

Pipeline Compounds:Approximately 20 compounds in clinical development incorporating Genmab innovation, aimed at treating serious diseases.

Antibody Technology Platforms:Proprietary technologies (four platforms) designed to create next-generation therapeutic antibodies.

therapeutic antibodies

Specialties

Antibody Science Cancer Treatment Therapeutic Antibodies Artificial Intelligence in Healthcare Drug Discovery and Development antibody research and development antibody technology platforms artificial intelligence

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 681500 MR: - FA: approximately DKK 4.7 million FAN: 681500	D: 2025-08-12 FD: 2025-08-12	-
2	RT: Employee Warrant Exercise T: - FT: Employee Warrant Exercise	A: 4662000 MR: - FA: approximately DKK 33.3 million FAN: 4662000	D: 2025-06-17 FD: 2025-06-17	-

Warrant Exercise Latest

2025-08-12

$682K

Employee Warrant Exercise 2025-06-17

$4.7M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jan G. J. Van de Winkel

President and Chief Executive Officer

A

Anthony Pagano

Executive Vice President and Chief Financial Officer

J

Judith Klimovsky

Executive Vice President & Chief Development Officer

T

Tahamtan Ahmadi

Executive Vice President and Chief Medical Officer, Head of Experimental Medicines

C

Christopher Cozic

Executive Vice President & Chief People Officer

M

Martine J. van Vugt

Executive Vice President and Chief Strategy Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Genmab A/S Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised